Do analysts rate LIAN or ABVC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LianBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 ABVC BioPharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is LIAN or ABVC more profitable?

LianBio's return on equity of -33.17% beat ABVC BioPharma's return on equity. Company Net Margins Return on Equity Return on Assets LianBio N/A -33.17% -30.19% ABVC BioPharma N/A -47.68% -30.97%

Do analysts recommend LIAN or QNTM?

Quantum Biopharma has a consensus target price of $8.00, indicating a potential upside of 176.82%. Given Quantum Biopharma's stronger consensus rating and higher probable upside, analysts plainly believe Quantum Biopharma is more favorable than LianBio. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LianBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Quantum Biopharma 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation and earnings, LIAN or QNTM?

Quantum Biopharma is trading at a lower price-to-earnings ratio than LianBio, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LianBio N/A N/A -$110.29M -$0.81 N/A Quantum Biopharma N/A N/A -$26.17M -$5.49 N/A

Is LIAN or QNTM more profitable?

LianBio's return on equity of -33.17% beat Quantum Biopharma's return on equity. Company Net Margins Return on Equity Return on Assets LianBio N/A -33.17% -30.19% Quantum Biopharma N/A -582.23% -184.20%

Do analysts recommend OPTH or LIAN?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Optimi Health 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 LianBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is OPTH or LIAN more profitable?

Optimi Health's return on equity of 0.00% beat LianBio's return on equity. Company Net Margins Return on Equity Return on Assets Optimi Health N/A N/A N/A LianBio N/A -33.17% -30.19%

Do analysts recommend PLRZ or LIAN?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Polyrizon 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 LianBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings and valuation, PLRZ or LIAN?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Polyrizon N/A N/A -$3.34M N/A N/A LianBio N/A N/A -$110.29M -$0.81 N/A

Is PLRZ or LIAN more profitable?

Polyrizon's return on equity of 0.00% beat LianBio's return on equity. Company Net Margins Return on Equity Return on Assets Polyrizon N/A N/A N/A LianBio N/A -33.17% -30.19%

Do analysts recommend LIAN or TXMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LianBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 TherapeuticsMD 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

LianBio (LIAN) Competitors

$0.05 0.00 (0.00%)

As of 10/13/2026

Compare

LIAN vs. ABVC, QNTM, OPTH, PLRZ, and TXMD

Should you buy LianBio stock or one of its competitors? LianBio's main competitors and comparable companies include ABVC BioPharma (ABVC), Quantum Biopharma (QNTM), Optimi Health (OPTH), Polyrizon (PLRZ), and TherapeuticsMD (TXMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does LianBio compare to ABVC BioPharma?

LianBio (NASDAQ:LIAN) and ABVC BioPharma (NASDAQ:ABVC) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, profitability and risk.

In the previous week, ABVC BioPharma had 1 more articles in the media than LianBio. MarketBeat recorded 1 mentions for ABVC BioPharma and 0 mentions for LianBio. ABVC BioPharma's average media sentiment score of 1.79 beat LianBio's score of 0.00 indicating that ABVC BioPharma is being referred to more favorably in the news media.

Company	Overall Sentiment
LianBio	Neutral
ABVC BioPharma	Very Positive

ABVC BioPharma has higher revenue and earnings than LianBio. ABVC BioPharma is trading at a lower price-to-earnings ratio than LianBio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LianBio	N/A	N/A	-$110.29M	-$0.81	N/A
ABVC BioPharma	$510K	51.23	-$7.91M	-$0.30	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LianBio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
ABVC BioPharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

LianBio has a beta of 0.23, meaning that its stock price is 77% less volatile than the broader market. Comparatively, ABVC BioPharma has a beta of 0.51, meaning that its stock price is 49% less volatile than the broader market.

LianBio's return on equity of -33.17% beat ABVC BioPharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LianBio	N/A	-33.17%	-30.19%
ABVC BioPharma	N/A	-47.68%	-30.97%

74.8% of LianBio shares are held by institutional investors. Comparatively, 11.4% of ABVC BioPharma shares are held by institutional investors. 7.6% of LianBio shares are held by insiders. Comparatively, 19.0% of ABVC BioPharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

ABVC BioPharma beats LianBio on 8 of the 11 factors compared between the two stocks.

How does LianBio compare to Quantum Biopharma?

LianBio (NASDAQ:LIAN) and Quantum Biopharma (NASDAQ:QNTM) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

In the previous week, Quantum Biopharma had 8 more articles in the media than LianBio. MarketBeat recorded 8 mentions for Quantum Biopharma and 0 mentions for LianBio. Quantum Biopharma's average media sentiment score of 0.43 beat LianBio's score of 0.00 indicating that Quantum Biopharma is being referred to more favorably in the news media.

Company	Overall Sentiment
LianBio	Neutral
Quantum Biopharma	Neutral

Quantum Biopharma is trading at a lower price-to-earnings ratio than LianBio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LianBio	N/A	N/A	-$110.29M	-$0.81	N/A
Quantum Biopharma	N/A	N/A	-$26.17M	-$5.49	N/A

Quantum Biopharma has a consensus target price of $8.00, indicating a potential upside of 176.82%. Given Quantum Biopharma's stronger consensus rating and higher probable upside, analysts plainly believe Quantum Biopharma is more favorable than LianBio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LianBio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Quantum Biopharma	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

74.8% of LianBio shares are held by institutional investors. Comparatively, 1.2% of Quantum Biopharma shares are held by institutional investors. 7.6% of LianBio shares are held by company insiders. Comparatively, 8.5% of Quantum Biopharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

LianBio has a beta of 0.23, meaning that its share price is 77% less volatile than the broader market. Comparatively, Quantum Biopharma has a beta of 0.39, meaning that its share price is 61% less volatile than the broader market.

LianBio's return on equity of -33.17% beat Quantum Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LianBio	N/A	-33.17%	-30.19%
Quantum Biopharma	N/A	-582.23%	-184.20%

Summary

Quantum Biopharma beats LianBio on 8 of the 12 factors compared between the two stocks.

How does LianBio compare to Optimi Health?

Optimi Health (NASDAQ:OPTH) and LianBio (NASDAQ:LIAN) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

74.8% of LianBio shares are held by institutional investors. 7.6% of LianBio shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Optimi Health's return on equity of 0.00% beat LianBio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Optimi Health	N/A	N/A	N/A
LianBio	N/A	-33.17%	-30.19%

Optimi Health has higher revenue and earnings than LianBio. Optimi Health is trading at a lower price-to-earnings ratio than LianBio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Optimi Health	$310K	64.69	-$1.12M	-$0.76	N/A
LianBio	N/A	N/A	-$110.29M	-$0.81	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Optimi Health	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
LianBio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Optimi Health had 3 more articles in the media than LianBio. MarketBeat recorded 3 mentions for Optimi Health and 0 mentions for LianBio. Optimi Health's average media sentiment score of 0.45 beat LianBio's score of 0.00 indicating that Optimi Health is being referred to more favorably in the media.

Company	Overall Sentiment
Optimi Health	Neutral
LianBio	Neutral

Summary

Optimi Health beats LianBio on 8 of the 10 factors compared between the two stocks.

How does LianBio compare to Polyrizon?

Polyrizon (NASDAQ:PLRZ) and LianBio (NASDAQ:LIAN) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation.

In the previous week, Polyrizon had 1 more articles in the media than LianBio. MarketBeat recorded 1 mentions for Polyrizon and 0 mentions for LianBio. Polyrizon's average media sentiment score of 0.91 beat LianBio's score of 0.00 indicating that Polyrizon is being referred to more favorably in the media.

Company	Overall Sentiment
Polyrizon	Positive
LianBio	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Polyrizon	N/A	N/A	-$3.34M	N/A	N/A
LianBio	N/A	N/A	-$110.29M	-$0.81	N/A

Polyrizon has a beta of -1.2, meaning that its stock price is 220% less volatile than the broader market. Comparatively, LianBio has a beta of 0.23, meaning that its stock price is 77% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Polyrizon	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
LianBio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Polyrizon's return on equity of 0.00% beat LianBio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Polyrizon	N/A	N/A	N/A
LianBio	N/A	-33.17%	-30.19%

Summary

Polyrizon beats LianBio on 6 of the 9 factors compared between the two stocks.

How does LianBio compare to TherapeuticsMD?

LianBio (NASDAQ:LIAN) and TherapeuticsMD (NASDAQ:TXMD) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

74.8% of LianBio shares are owned by institutional investors. Comparatively, 30.7% of TherapeuticsMD shares are owned by institutional investors. 7.6% of LianBio shares are owned by company insiders. Comparatively, 1.7% of TherapeuticsMD shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, TherapeuticsMD had 2 more articles in the media than LianBio. MarketBeat recorded 2 mentions for TherapeuticsMD and 0 mentions for LianBio. TherapeuticsMD's average media sentiment score of 0.91 beat LianBio's score of 0.00 indicating that TherapeuticsMD is being referred to more favorably in the news media.

Company	Overall Sentiment
LianBio	Neutral
TherapeuticsMD	Positive

TherapeuticsMD has higher revenue and earnings than LianBio. LianBio is trading at a lower price-to-earnings ratio than TherapeuticsMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LianBio	N/A	N/A	-$110.29M	-$0.81	N/A
TherapeuticsMD	$3.02M	7.51	-$570K	$0.02	98.00

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LianBio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
TherapeuticsMD	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

LianBio has a net margin of 0.00% compared to TherapeuticsMD's net margin of -6.64%. TherapeuticsMD's return on equity of -1.09% beat LianBio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LianBio	N/A	-33.17%	-30.19%
TherapeuticsMD	-6.64%	-1.09%	-0.78%

LianBio has a beta of 0.23, suggesting that its share price is 77% less volatile than the broader market. Comparatively, TherapeuticsMD has a beta of 0.65, suggesting that its share price is 35% less volatile than the broader market.

Summary

TherapeuticsMD beats LianBio on 10 of the 13 factors compared between the two stocks.

Get LianBio News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LIAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LIAN vs. The Competition

Export

Metric	LianBio	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$5.51M	$12.40B	$7.29B	$12.91B
Dividend Yield	N/A	2.63%	2.51%	22.89%
P/E Ratio	-0.06	807.80	275.68	25.25
Price / Sales	N/A	748.52	562.78	78.51
Price / Cash	N/A	86.65	77.16	53.04
Price / Book	0.02	9.19	10.54	5.92
Net Income	-$110.29M	$2.84B	$3.50B	$381.16M
7 Day Performance	N/A	-4.30%	-4.13%	-4.32%
1 Month Performance	N/A	-8.36%	-8.51%	-7.19%
1 Year Performance	N/A	-6.14%	2.12%	-4.99%

LianBio Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LIAN LianBio	N/A	$0.05 flat	N/A	-29.3%	$5.51M	N/A	N/A	110	Gap Up
ABVC ABVC BioPharma	0.7496 of 5 stars	$1.00 +3.1%	N/A	-66.9%	$25.89M	$510K	N/A	19	Positive News Gap Up
QNTM Quantum Biopharma	1.855 of 5 stars	$3.14 +1.6%	$8.00 +154.8%	-81.0%	$24.99M	N/A	N/A	7
OPTH Optimi Health	0.3377 of 5 stars	$4.04 -2.2%	N/A	N/A	$23.65M	$310K	N/A	9
PLRZ Polyrizon	1.0811 of 5 stars	$9.15 -5.4%	N/A	+37.6%	$23.48M	N/A	N/A	1	Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LIAN) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

LianBio (LIAN) Competitors

LIAN vs. ABVC, QNTM, OPTH, PLRZ, and TXMD

How does LianBio compare to ABVC BioPharma?

Summary

How does LianBio compare to Quantum Biopharma?

Summary

How does LianBio compare to Optimi Health?

Summary

How does LianBio compare to Polyrizon?

Summary

How does LianBio compare to TherapeuticsMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LIAN vs. The Competition

LianBio Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

LianBio (LIAN) Competitors

LIAN vs. ABVC, QNTM, OPTH, PLRZ, and TXMD

How does LianBio compare to ABVC BioPharma?

Does the media prefer LIAN or ABVC?

Which has better earnings and valuation, LIAN or ABVC?

Do analysts rate LIAN or ABVC?

Which has more volatility & risk, LIAN or ABVC?

Is LIAN or ABVC more profitable?

Do institutionals and insiders hold more shares of LIAN or ABVC?

Summary

How does LianBio compare to Quantum Biopharma?

Does the media prefer LIAN or QNTM?

Which has higher valuation and earnings, LIAN or QNTM?

Do analysts recommend LIAN or QNTM?

Do insiders and institutionals hold more shares of LIAN or QNTM?

Which has more volatility and risk, LIAN or QNTM?

Is LIAN or QNTM more profitable?

Summary

How does LianBio compare to Optimi Health?

Do institutionals & insiders believe in OPTH or LIAN?

Is OPTH or LIAN more profitable?

Which has better valuation & earnings, OPTH or LIAN?

Do analysts recommend OPTH or LIAN?

Does the media refer more to OPTH or LIAN?

Summary

How does LianBio compare to Polyrizon?

Does the media prefer PLRZ or LIAN?

Do institutionals and insiders have more ownership in PLRZ or LIAN?

Which has preferable earnings and valuation, PLRZ or LIAN?

Which has more volatility & risk, PLRZ or LIAN?

Do analysts recommend PLRZ or LIAN?

Is PLRZ or LIAN more profitable?

Summary

How does LianBio compare to TherapeuticsMD?

Do insiders and institutionals hold more shares of LIAN or TXMD?

Does the media refer more to LIAN or TXMD?

Which has higher earnings & valuation, LIAN or TXMD?

Do analysts recommend LIAN or TXMD?

Is LIAN or TXMD more profitable?

Which has more risk and volatility, LIAN or TXMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LIAN vs. The Competition

LianBio Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools